Chinese Firm Sinopharm Reports Promising Results for COVID-19 Vaccine Trials
The anti-Covid vaccine from the Chinese pharmaceutical group Sinopharm, chosen by Morocco, is about to be completed thanks to the results of clinical trials.
In a press release, the pharmaceutical group indicated on Wednesday, November 11 that the data obtained from the large-scale clinical trials were "better than expected".
According to Reuters, the 3rd phase of clinical trials has been launched for the two vaccine candidates by China National Biotec Group (CNBG), which is a Sinopharm unit. These trials have been conducted in the United Arab Emirates, Bahrain and Egypt on more than 50,000 volunteers from these countries.
Pending the completion of the trials, the group should provide more details on the data from the trials of one of the two group’s vaccines.
Related Articles
-
Morocco Cracks Down on Rampant Misuse of State Vehicles by Officials
9 September 2025
-
Morocco-Algeria Rift Deepens: King’s Peace Overtures Fall on Deaf Ears
9 September 2025
-
Morocco’s New License Plates Spark Nationwide Controversy: Drivers Fined for Legal Tags
8 September 2025
-
Severe Weather Alert: Thunderstorms and Gusty Winds to Batter Multiple Moroccan Regions
8 September 2025
-
Ryanair Flight Fiasco: Passengers Stranded in Rabat as Plane Lands in Fez Without Them
8 September 2025